IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: CYBERKEN who wrote (1119)	10/27/1998 8:29:00 AM
From: John S. Baker	Read Replies (2) of 1510

No doubt, David, that bio-tech development companies involve considerable risk, and from time to time provide a sufficient return to justify that risk. But IMNR is clearly not a one-product company. They have a variety of applications of their T-cell technology coming along (for everything from psoriasis to prostate cancer), so I personally consider the risk to be somewhat lessened. Nevertheless, Happy Due Diligence! This stuff is not for widows and orphans, and nothing is guaranteed. JSb.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next